Horan Securities’s Vertex Pharmaceuticals VRTX Stock Holding History

Horan Securities’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-9	Closed	-$3.17K	–	656
2023 Q2	$3.17K	Hold	9	–	–	﹤0.01%	525
2023 Q1	$2.84K	Hold	9	–	–	﹤0.01%	528
2022 Q4	$2.6K	Hold	9	–	–	﹤0.01%	533
2022 Q3	$3K	Hold	9	–	–	﹤0.01%	460
2022 Q2	$3K	Hold	9	–	–	﹤0.01%	513
2022 Q1	$2K	Hold	9	–	–	﹤0.01%	460
2021 Q4	$2K	Buy	+9	New	+$1.75K	﹤0.01%	463
2021 Q2	$2K	Hold	9	–	–	﹤0.01%	417
2021 Q1	$2K	Buy	+9	New	+$1.98K	﹤0.01%	377
2020 Q3	–	Sell	-23	Closed	-$7K	–	396
2020 Q2	$7K	Hold	23	–	–	0.01%	222
2020 Q1	$5K	Buy	+23	New	+$5.28K	0.01%	175

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return